NEW YORK (360Dx) – Even as the deaths of former National Football League players have put the spotlight on concussions, diagnosing the injury remains a tricky business, sometimes relying on art as well as science.

Boston-based BioDirection hopes to change that with a blood-based test that it said can offer an objective diagnosis within 90 seconds. If all goes according to plan, the test could hit the market in Europe in about a year, followed by a launch in the US.

Get the full story with
360Dx Premium

Only $95 for the
first 90 days*

A trial upgrade to 360Dx Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try 360Dx Premium now.

Already a 360Dx Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.